Follow
Christopher D. O. Cooper
Christopher D. O. Cooper
Director & Head of Protein Sciences, CHARM Therapeutics
Verified email at charmtx.com - Homepage
Title
Cited by
Cited by
Year
Microrna expression distinguishes between germinal center B cell‐like and activated B cell‐like subtypes of diffuse large B cell lymphoma
CH Lawrie, S Soneji, T Marafioti, C Cooper, S Palazzo, JC Paterson, ...
International Journal of Cancer 121 (5), 1156-1161, 2007
5212007
High-throughput production of human proteins for crystallization: the SGC experience
P Savitsky, J Bray, CDO Cooper, BD Marsden, P Mahajan, ...
Journal of structural biology 172 (1), 3-13, 2010
3412010
Structural basis for Cul3 protein assembly with the BTB-Kelch family of E3 ubiquitin ligases
P Canning, CDO Cooper, T Krojer, JW Murray, ACW Pike, A Chaikuad, ...
Journal of Biological Chemistry 288 (11), 7803-7814, 2013
2922013
PHF8, a gene associated with cleft lip/palate and mental retardation, encodes for an Nε-dimethyl lysine demethylase
C Loenarz, W Ge, ML Coleman, NR Rose, CDO Cooper, RJ Klose, ...
Human molecular genetics 19 (2), 217-222, 2010
1832010
MicroRNA expression in lymphocyte development and malignancy
CH Lawrie, NJ Saunders, S Soneji, S Palazzo, HM Dunlop, CDO Cooper, ...
Leukemia 22 (7), 1440-1447, 2008
1182008
Mutations in multidomain protein MEGF8 identify a Carpenter syndrome subtype associated with defective lateralization
SRF Twigg, D Lloyd, D Jenkins, NE Elçioglu, CDO Cooper, N Al-Sannaa, ...
The American Journal of Human Genetics 91 (5), 897-905, 2012
1032012
Structure of the Helicase Domain of DNA Polymerase Theta Reveals a Possible Role in the Microhomology-Mediated End-Joining Pathway
JA Newman, CDO Cooper, H Aitkenhead, O Gileadi
Structure 23 (12), 2319-2330, 2015
872015
Defective ALC1 nucleosome remodeling confers PARPi sensitization and synthetic lethality with HRD
G Hewitt, V Borel, S Segura-Bayona, T Takaki, P Ruis, R Bellelli, ...
Molecular cell 81 (4), 767-783. e11, 2021
822021
A prominent β-hairpin structure in the winged-helix domain of RECQ1 is required for DNA unwinding and oligomer formation
B Lucic, Y Zhang, O King, R Mendoza-Maldonado, M Berti, FH Niesen, ...
Nucleic acids research 39 (5), 1703-1717, 2011
732011
Structural insights into the function of ZRANB3 in replication stress response
M Sebesta, CDO Cooper, A Ariza, CJ Carnie, D Ahel
Nature Communications 8, ncomms15847, 2017
542017
Structures of the Ets Protein DNA-binding Domains of Transcription Factors Etv1, Etv4, Etv5, and Fev DETERMINANTS OF DNA BINDING AND REDOX REGULATION BY DISULFIDE BOND FORMATION
CDO Cooper, JA Newman, H Aitkenhead, CK Allerston, O Gileadi
Journal of Biological Chemistry 290 (22), 13692-13709, 2015
512015
Recent advances in the structural molecular biology of Ets transcription factors: interactions, interfaces and inhibition.
CD Cooper, JA Newman, O Gileadi
Biochemical Society Transactions 42 (1), 130-138, 2014
502014
MORC4, a novel member of the MORC family, is highly expressed in a subset of diffuse large B‐cell lymphomas
AP Liggins, C Cooper, CH Lawrie, PJ Brown, GP Collins, CS Hatton, ...
British journal of haematology 138 (4), 479-486, 2007
482007
Crystal structure of the PHF8 Jumonji domain, an N ε-methyl lysine demethylase
WW Yue, V Hozjan, W Ge, C Loenarz, CDO Cooper, CJ Schofield, ...
FEBS letters 584 (4), 825-830, 2010
462010
Structures of Two Melanoma-Associated Antigens Suggest Allosteric Regulation of Effector Binding
JA Newman, CDO Cooper, AK Roos, H Aitkenhead, UCT Oppermann, ...
PLOS ONE 11 (2), e0148762, 2016
402016
PASD1, a DLBCL-associated cancer testis antigen and candidate for lymphoma immunotherapy
CDO Cooper, AP Liggins, K Ait-Tahar, G Roncador, AH Banham, ...
Leukemia 20 (12), 2172-2172, 2006
402006
Expressing the human proteome for affinity proteomics: optimising expression of soluble protein domains and in vivo biotinylation
T Keates, CDO Cooper, P Savitsky, CK Allerston, C Phillips, ...
New biotechnology 29 (5), 515-525, 2012
372012
PASD1 is a potential multiple myeloma–associated antigen
SS Sahota, CM Goonewardena, CDO Cooper, AP Liggins, K Ait-Tahar, ...
Blood 108 (12), 3953-3955, 2006
322006
The Controversial Roles of ADP-Ribosyl Hydrolases MACROD1, MACROD2 and TARG1 in Carcinogenesis
KLH Feijs, C Cooper, R Žaja
Cancers 12 (3), 604, 2020
242020
Aberrant expression of microRNA biosynthetic pathway components is a common feature of haematological malignancy
CH Lawrie, C Cooper, E Ballabio, J Chi, D Tramonti, CSR Hatton
British journal of haematology 145 (4), 545-548, 2009
192009
The system can't perform the operation now. Try again later.
Articles 1–20